ORKA ▼ -0.6% - Oruka Therapeutics, Inc.
$ORKA - Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing
Oruka Therapeutics announced positive Week 28 data from its EVERLAST-A trial for ORKA-001, demonstrating that treatment responses continued to deepen without requiring additional dosing. Despite the favorable clinical results, the stock declined 0.6% today, suggesting investors may have been pricing in positive data or had other concerns offsetting the announcement.
23-SEP-2026 07:00 AM ET
Share this post
More filings for $ORKA
ORKA - Oruka Therapeutics, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026ORKA ▲ +1.0% - Oruka Therapeutics, Inc.Nov 9, 2026ORKA ▼ -0.0% - Oruka Therapeutics, Inc.Nov 3, 2026ORKA ▼ -2.0% - Oruka Therapeutics, Inc.Oct 26, 2026ORKA ▼ -1.2% - Oruka Therapeutics, Inc.Oct 25, 2026ORKA ▼ -3.1% - Oruka Therapeutics, Inc.Sep 9, 2026
View full $ORKA filing history →💬 Comments
Loading comments…
Leave a comment
